(Q36577453)

15 August 2017

1 reference

title

Diagnostic significance of ANCA in vasculitis (English)

1 reference

15 August 2017

Elena Csernok

1

1 reference

PubMed ID

16932679

15 August 2017

Peter Lamprecht

series ordinal

2

1 reference

PubMed ID

16932679

15 August 2017

Wolfgang L Gross

series ordinal

3

1 reference

15 August 2017

1 April 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

4

1 reference

15 August 2017

174-175

1 reference

The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0159

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0159

1 reference

15 August 2017

1 reference

PubMed ID

16932679